AMAG PHARMACEUTICALS INC.·4

Mar 5, 6:03 PM ET

Grund Nicholas 4

4 · AMAG PHARMACEUTICALS INC. · Filed Mar 5, 2019

Insider Transaction Report

Form 4
Period: 2019-03-02
Grund Nicholas
Chief Commercial Officer
Transactions
  • Tax Payment

    Common Stock

    2019-03-02$14.76/sh982$14,49484,805 total
Footnotes (1)
  • [F1]Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 3,333 restricted stock units on March 2, 2019.

Documents

1 file
  • 4
    wf-form4_155182696960170.xmlPrimary

    FORM 4